Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

NCT00425256 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Sexual Arousal Disorder

Interventions

DRUG: Bremelanotide

Sponsor

Palatin Technologies, Inc

Collaborators

[object Object]